Polydex Pharmaceuticals Ltd. (OTCMKTS:POLXF – Get Free Report) crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $1.99 and traded as low as $1.9860. Polydex Pharmaceuticals shares last traded at $1.9860, with a volume of 2,000 shares changing hands.
Polydex Pharmaceuticals Stock Performance
The company has a 50-day moving average of $1.99 and a 200-day moving average of $1.99.
About Polydex Pharmaceuticals
Polydex Pharmaceuticals Ltd. is a development stage company, which engages in manufacturing of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, and the development, manufacturing, and marketing of biotechnology-based products for the human pharmaceutical market.
Read More
- Five stocks we like better than Polydex Pharmaceuticals
- What Is WallStreetBets and What Stocks Are They Targeting?
- Tesla Has Been Trapped in a 10% Range for Months—What’s Going On?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- dLocal Falls Despite Blowout Q3 Results—What Investors Are Missing
- How to Profit From Growth Investing
- Ondas Holdings Signals a Rebound as Drone Demand Soars
Receive News & Ratings for Polydex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polydex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
